Triazolines XV. Anticonvulsant Profile of ADD 17014, a Potentially Unique 1,2,3‐Triazoline Antiepileptic Drug, in Mice and Rats

Medicine and Dentistry

• Anticonvulsant 100%
• Phenobarbital 100%
• Pentylenetetrazol 83%
• Bicuculline 83%
• Maximal Electroshock Seizure 83%
• Sodium Valproate 83%
• In Vitro 50%
• Glutamic Acid 50%
• Picrotoxin 50%
• Oral Drug Administration 33%
• Indican 33%
• Ethosuximide 33%
• Prodrug 33%
• Phenytoin 33%
• Family 16%
• Epileptic Seizure 16%
• Alcohol 16%
• Glutamate Receptor 16%
• Intraperitoneal Drug Administration 16%
• Receptor Binding 16%
• Electric Shock 16%
• Excitatory Amino Acid Receptor Antagonist 16%
• Anticonvulsant Activity 16%
• Aminoalcohol 16%
• Metabolite 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticonvulsive Agent 100%
• Rat 100%
• Phenobarbital 85%
• Sodium Valproate 71%
• Pentetrazole 71%
• Bicuculline 71%
• Maximal Electroshock Seizure 71%
• Picrotoxin 42%
• Glutamic Acid 42%
• Median Toxic Dose 42%
• Prodrug 28%
• Phenytoin 28%
• Indican 28%
• Ethosuximide 28%
• Ethanol 14%
• Anticonvulsant Activity 14%
• Amino Acid Receptor Blocking Agent 14%
• Receptor 14%
• Seizure 14%
• Electric Shock 14%
• Strychnine 14%
• Aminoalcohol 14%
• Glutamate Receptor 14%

Arts and Humanities

• Testing 100%
• Rat 100%
• Oral 41%
• Administration 41%
• Dosage 33%
• Indexes 25%
• Crisis 8%
• Exceptions 8%
• Spectre 8%
• Antagonist 8%
• Alto 8%
• Originales 8%
• Family Novel 8%
• Structure 8%
• Binding 8%
• Protection 8%